A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study

  • Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, Takashi Ogura, Shunichiro Iwasawa, Tae Iwasawa, Rika Kasajima, Yohei Miyagi, Toshihiro Misumi, Takeharu Yamanaka, Hiroaki Okamoto
  • Therapeutic Advances in Medical Oncology, January 2020, SAGE Publications
  • DOI: 10.1177/1758835920922022

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1177/1758835920922022

The following have contributed to this page: Satoshi Ikeda